2024 ICD-10-CM Diagnosis Code E34.321
Primary insulin-like growth factor-1 (IGF-1) deficiency
- ICD-10-CM Code:
- E34.321
- ICD-10 Code for:
- Primary insulin-like growth factor-1 (IGF-1) deficiency
- Is Billable?
- Yes - Valid for Submission
- Chronic Condition Indicator: [1]
- Chronic
- Code Navigator:
E34.321 is a billable diagnosis code used to specify a medical diagnosis of primary insulin-like growth factor-1 (igf-1) deficiency. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Growth delay due to insulin-like growth factor type 1 deficiency
- Growth hormone receptor abnormality
- Growth hormone receptor absent
- Hereditary growth hormone deficiency
- Laron syndrome with immunodeficiency
- Laron-type isolated somatotropin defect
- Short stature due to primary acid labile subunit deficiency
Clinical Classification
Clinical Category is Other specified and unspecified endocrine disorders
- CCSR Category Code: END015
- Inpatient Default CCSR: Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.
- Outpatient Default CCSR: Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.
Tabular List of Diseases and Injuries
The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.
Inclusion Terms
Inclusion TermsThese terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Acid-labile subunit gene (IGFALS) defect
- Growth hormone gene 1 (GH1) defect with growth hormone neutralizing antibodies
- Growth hormone insensitivity syndrome (GHIS)
- Insulin-like growth factor 1 gene (IGF1) defect
- Laron type short stature
- Severe primary insulin-like growth factor-1 deficiency (SPIGFD)
- Signal transducer and activator of transcription 5B gene (STAT5b) defect
Index to Diseases and Injuries References
The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).
- - Dwarfism - See Also: Short, stature; - E34.328
- - Laron-type - See Also: Short, stature; - E34.321
- - Short, shortening, shortness
- - stature (child) (hereditary) (idiopathic) NEC - R62.52
- - due to
- - genetic causes - E34.329
- - acid-labile subunit gene (IGFALS) defect - E34.321
- - growth hormone gene 1 (GH1) defect with growth hormone neutralizing antibodies - E34.321
- - growth hormone insensitivity syndrome (GHIS) - E34.321
- - insulin-like growth factor 1 gene (IGF1) defect - E34.321
- - primary insulin-like growth factor-1 (IGF-1) deficiency - E34.321
- - severe primary insulin-like growth factor-1 deficiency (SPIGFD) - E34.321
- - signal transducer and activator of transcription 5B gene (STAT5b) defect - E34.321
- - genetic causes - E34.329
- - Laron-type - E34.321
- - due to
- - stature (child) (hereditary) (idiopathic) NEC - R62.52
Replacement Code
E34321 replaces the following previously assigned ICD-10-CM code(s):
- E34.3 - Short stature due to endocrine disorder
Code History
- FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
- FY 2023 - Code Added, effective from 10/1/2022 through 9/30/2023
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.